DEDaphne S. Everaerd

Daphne S. Everaerd

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daphne S. Everaerd has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical Outcomes of a 3-day Benzodiazepine Detoxification Protocol With Continuous Subcutaneous Flumazenil Infusion: An Open-label Pilot Study

    by Damian A. Visser, Erik P. Paling, Daphne S. Everaerd, Nens van Alfen, Janneke R. Zinkstok, Indira Tendolkar, Cornelis Kramers, Arnt F.A. Schellekens

    Objectives: Abstinence rates of benzodiazepine tapering in individuals with sedative, hypnotic, or anxiolytic use disorder (SHA‑UD) are approximately 50%. Continuous subcutaneous flumazenil infusion during tapering may increase success rates and shorten tapering regimens; however, data on safety and effectiveness remain limited. We therefore aimed to assess the safety, withdrawal symptoms, and abstinence rates associated with flumazenil‑assisted 3-day benzodiazepine tapering in individuals with SHA‑UD. Methods: This exploratory, single‑arm, open‑label pilot study included adult participants with SHA‑UD (n=31) who had experienced at least one previous unsuccessful professionally guided tapering attempt. Participants received a 6‑day continuous subcutaneous flumazenil infusion (4 mg/24 h), while benzodiazepines were fully tapered during the first 3 days. Outcomes included adverse events, interictal epileptiform discharges (IEDs) on EEG, withdrawal severity, anxiety, and abstinence rates at 3‑month follow‑up. Results: After a withdrawal seizure occurred in one of the first 4 participants, valproate prophylaxis was introduced; no further seizures were observed thereafter. IEDs were detected in 6 participants during or after flumazenil infusion. Supportive medication (eg, propranolol, promethazine) was required in 87% of participants to manage withdrawal symptoms. Withdrawal severity and anxiety increased during detoxification, peaking during the final days of flumazenil infusion ( P =0.023). Sixteen participants (52%) were confirmed abstinent at 3-month follow-up by self-report and urinalysis. Conclusions: These findings warrant further investigation of flumazenil-assisted benzodiazepine detoxification in individuals with SHA-UD. Controlled studies are needed to further establish its safety profile and comparative effectiveness.

  • Good vibrations: An observational study of real-life stress induced by a stage performance

    by Daphne S. Everaerd, Marloes J.A.G. Henckens, Mirjam Bloemendaal, Leonore Bovy, Reinoud Kaldewaij, Frederique M.W.M. Maas, Peter C.R. Mulders, Hannah C.M. Niermann, Iris van de Pavert, Izabela Przezdzik, et al.


  • Childhood abuse and deprivation are associated with distinct sex-dependent differences in brain morphology

    by Daphne Everaerd, Floris Klumpers, Marcel Zwiers, Tulio Guadalupe, Barbara Franke, Iris van Oostrom, Aart Schene, Guillén Fernández, Indira Tendolkar

    Childhood adversity (CA) has been associated with long-term structural brain alterations and an increased risk for psychiatric disorders. Evidence is emerging that subtypes of CA, varying in the dimensions of threat and deprivation, lead to distinct neural and behavioral outcomes. However, these specific associations have yet to be established without potential confounders such as psychopathology. Moreover, differences in neural development and psychopathology necessitate the exploration of sexual dimorphism. Young healthy adult subjects were selected based on history of CA from a large database to assess gray matter (GM) differences associated with specific subtypes of adversity. We compared voxel-based morphometry data of subjects reporting specific childhood exposure to abuse (n=127) or deprivation (n=126) and a similar sized group of controls (n=129) without reported CA. Subjects were matched on age, gender, and educational level. Differences between CA subtypes were found in the fusiform gyrus and middle occipital gyrus, where subjects with a history of deprivation showed reduced GM compared with subjects with a history of abuse. An interaction between sex and CA subtype was found. Women showed less GM in the visual posterior precuneal region after both subtypes of CA than controls. Men had less GM in the postcentral gyrus after childhood deprivation compared with abuse. Our results suggest that even in a healthy population, CA subtypes are related to specific alterations in brain structure, which are modulated by sex. These findings may help understand neurodevelopmental consequences related to CA.